Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: MIT Dean Joins Bruker Board and More

Premium

Bruker said this week that Mark Kastner, dean of the School of Science at the Massachusetts Institute of Technology, has been elected to a seat on its board of directors. He is replacing Charles Wagner, who left the board last year to become Bruker's chief financial officer.

Kastner has been a physics professor at MIT since 1973, and he has served as director of the MIT Center for Materials Science and Engineering and as head of the MIT Department of Physics.


CombiMatrix said this week that chief commercial officer Mark McDonough will take over as CEO effective March 15, replacing Judd Jessup, who is retiring.

McDonough joined CombiMatrix in August 2012 from Pathwork Diagnostics, where he was vice president of sales, customer service, and training. He also has worked for US Labs, Dianon, Laboratory Corporation of America, EMC, and Ventana Medical Systems.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.